CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $643,897 | -7.6% | 55,081 | +6.3% | 0.00% | 0.0% |
| Q2 2023 | $696,622 | -20.6% | 51,832 | -2.0% | 0.00% | -33.3% |
| Q1 2023 | $876,817 | -10.4% | 52,884 | +0.5% | 0.01% | -14.3% |
| Q4 2022 | $979,085 | +45.7% | 52,639 | +0.5% | 0.01% | +40.0% |
| Q3 2022 | $672,000 | +114.0% | 52,394 | +16.8% | 0.01% | +150.0% |
| Q2 2022 | $314,000 | -21.5% | 44,846 | -7.0% | 0.00% | 0.0% |
| Q1 2022 | $400,000 | +14.6% | 48,208 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $349,000 | +23.8% | 51,602 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $282,000 | -9.9% | 53,145 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $313,000 | +19.9% | 54,409 | -3.8% | 0.00% | 0.0% |
| Q1 2021 | $261,000 | +38.8% | 56,570 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $188,000 | +9.3% | 56,420 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $172,000 | -37.2% | 58,039 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $274,000 | +24.5% | 59,358 | +3.9% | 0.00% | 0.0% |
| Q1 2020 | $220,000 | -3.1% | 57,105 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $227,000 | -29.7% | 60,405 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $323,000 | +36.9% | 60,912 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $236,000 | -24.8% | 61,337 | -0.3% | 0.00% | 0.0% |
| Q1 2019 | $314,000 | +157.4% | 61,509 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $122,000 | -49.6% | 63,503 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $242,000 | +23.5% | 63,991 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $196,000 | +46.3% | 62,838 | +12.3% | 0.00% | – |
| Q1 2018 | $134,000 | -28.7% | 55,935 | +16.1% | 0.00% | -100.0% |
| Q4 2017 | $188,000 | +55.4% | 48,193 | +0.5% | 0.00% | – |
| Q3 2017 | $121,000 | -0.8% | 47,965 | +8.1% | 0.00% | – |
| Q2 2017 | $122,000 | -99.8% | 44,379 | +0.6% | 0.00% | – |
| Q1 2016 | $52,000,000 | -51.9% | 44,119 | 0.0% | 0.00% | – |
| Q4 2015 | $108,000,000 | +81103.0% | 44,119 | -0.2% | 0.00% | -100.0% |
| Q3 2015 | $133,000 | -99.9% | 44,196 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $182,315,000 | +3503.1% | 44,144 | +2107.2% | 0.00% | – |
| Q2 2014 | $5,060,000 | +11.9% | 2,000 | 0.0% | 0.00% | – |
| Q1 2014 | $4,520,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |